These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 13741922)
1. [Nor-steroids in functional mastopathies]. RIUSECH G Sem Med; 1961 Jul; 119():87-9. PubMed ID: 13741922 [No Abstract] [Full Text] [Related]
2. [The nor-steroids in the treatment of sclerocystic mastopathy]. REMY SOLA EF; INZA R Sem Med; 1960 Dec; 117():2072-3. PubMed ID: 13740801 [No Abstract] [Full Text] [Related]
3. [Metabolism and metabolic reaction following the infusion of dehydro-epiandrosterone-phosphate in breast cancer and mastopathies. 3. Behavior of estrogens]. Schubert K; Bacigalupo G Arch Geschwulstforsch; 1965; 25(3):189-94. PubMed ID: 4220617 [No Abstract] [Full Text] [Related]
5. [Peculiarities of steroid metabolism in mastopathy and breast cancer under the effect of testosterone]. SCHUBERT K; BACIGALUPO G Arch Geschwulstforsch; 1960; 16():222-37. PubMed ID: 13748718 [No Abstract] [Full Text] [Related]
6. [Immunohistological studies for demonstration of carcinoembryonic antigen in benign breast lesions]. Wittekind C; von Kleist S; Sandritter W Onkologie; 1982 Aug; 5 Suppl():25-7. PubMed ID: 6752789 [TBL] [Abstract][Full Text] [Related]
7. [Growth factors of cultured epithelial cells of breast diseases and breast carcinoma]. Salle V; Souttou B; Magnien V; Israël L; Crépin M Bull Cancer; 1992; 79(2):133-40. PubMed ID: 1392152 [TBL] [Abstract][Full Text] [Related]
13. Benign breast disease: studies of prostaglandin E2, steroids, and thermographic effects of inhibitors of prostaglandin biosynthesis. Rolland PH; Martin PM; Rolland AM; Bourry M; Serment H Obstet Gynecol; 1979 Dec; 54(6):715-8. PubMed ID: 514558 [TBL] [Abstract][Full Text] [Related]
14. [Growth acceleration with new anabolic steroids]. SCHARER K; HABICH H; PRADER A Helv Med Acta; 1960 Dec; 27():530-4. PubMed ID: 13747284 [No Abstract] [Full Text] [Related]
18. Evaluation of equine urine reactivity towards phase II metabolites of 17-hydroxy steroids by liquid chromatography/tandem mass spectrometry. Fidani M; Gamberini MC; Pasello E; Palazzoli F; De Iuliis P; Montana M; Arioli F Rapid Commun Mass Spectrom; 2009 Jan; 23(1):65-76. PubMed ID: 19051232 [TBL] [Abstract][Full Text] [Related]
19. [Biologic bases of the treatment of diffuse benign breast diseases]. Van Bogaert LJ J Gynecol Obstet Biol Reprod (Paris); 1976 Jun; 5(4):567-75. PubMed ID: 783246 [TBL] [Abstract][Full Text] [Related]